Ray ongoing, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology have been instrumental to shaping the development of STK-012, our very first-in-class alpha/beta biased IL-2. Its distinctive mechanism expands the therapeutic index of IL-two, amongst https://https-www-zosanopharma-co54208.life3dblog.com/35456589/not-known-facts-about-https-www-zosanopharma-com-technology